StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Ammonium Chloride → acetic acid 2-[5-(5-azetidin-1-ylmethyl-1-methyl-1H-pyrazol-3-ylamino)-1-methyl-6-oxo-1,6-dihydro-pyridazin-3-yl]-6-(6-tert-butyl-8-fluoro-1-oxo-1H-phthalazin-2-yl)-benzyl ester

HRID 449677
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 449677
[C:1]([O:4][CH2:5][C:6]1[C:11](B2OC(C)(C)C(C)(C)O2)=[CH:10][CH:9]=[CH:8][C:7]=1[N:21]1[N:30]=[CH:29][C:28]2[C:23](=[C:24]([F:35])[CH:25]=[C:26]([C:31]([CH3:34])([CH3:33])[CH3:32])[CH:27]=2)[C:22]1=[O:36])(=[O:3])[CH3:2].[N:37]1([CH2:41][C:42]2[N:46]([CH3:47])[N:45]=[C:44]([NH:48][C:49]3[C:50](=[O:57])[N:51]([CH3:56])[N:52]=[C:53](Cl)[CH:54]=3)[CH:43]=2)[CH2:40][CH2:39][CH2:38]1.P([O-])([O-])([O-])=O.[K+].[K+].[K+].C1(P(C2CCCCC2)C2C=CC=CC=2C2C(C(C)C)=CC(C(C)C)=CC=2C(C)C)CCCCC1.[Cl-].[NH4+]>C(O)CCC.O>[N:37]1([CH2:41][C:42]2[N:46]([CH3:47])[N:45]=[C:44]([NH:48][C:49]3[C:50](=[O:57])[N:51]([CH3:56])[N:52]=[C:53]([C:11]4[CH:10]=[CH:9][CH:8]=[C:7]([N:21]5[N:30]=[CH:29][C:28]6[C:23](=[C:24]([F:35])[CH:25]=[C:26]([C:31]([CH3:33])([CH3:34])[CH3:32])[CH:27]=6)[C:22]5=[O:36])[C:6]=4[CH2:5][O:4][C:1](=[O:3])[CH3:2])[CH:54]=3)[CH:43]=2)[CH2:40][CH2:39][CH2:38]1
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

8

Edukt 5

HCID 25517Ammonium ChlorideHCID 62657Potassium Phosphate, TribasicHCID 111557942-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 58540099HCID 58540099, VerbindungHCID 594737692-(6-(tert-Butyl)-8-fluoro-1-oxophthalazin-2(1H)-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acetate

Produkt 1

HCID 66742536
acetic acid 2-[5-(5-azetidin-1-ylmethyl-1-methyl-1H-pyrazol-3-ylamino)-1-methyl-6-oxo-1,6-dihydro-pyridazin-3-yl]-6-(6-tert-butyl-8-fluoro-1-oxo-1H-phthalazin-2-yl)-benzyl ester
Ausbeute 32 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 2631-ButanolLösungsmittelHCID 962WaterLösungsmittel

Reaktionsbedingungen

Temperatur
100 °C

Versuchsvorschrift

A solution of 2-(6-tert-butyl-8-fluoro-1-oxophthalazin-2(1H)-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acetate (498 mg, 1.01 mmol), 4-(5-(azetidin-1-ylmethyl)-1-methyl-1H-pyrazol-3-ylamino)-6-chloro-2-methylpyridazin-3(2H)-one (183 mg, 0.59 mmol), potassium phosphate (315 mg, 1.48 mmol) and dicyclohexyl(2′,4′,6′-triisopropylbiphenyl-2-yl)phosphine (28.3 mg, 0.06 mmol) in butanol (4 ml) and water (1 mL) was flushed with argon before (bis[dibenzylideneacetone]dipalladium) (17.0 mg, 0.03 mmol) was added and the resulting solution heated at 100° C. in for 2 h. The resulting mixture was cooled, poured into a saturated solution of ammonium chloride and extracted with methylene chloride (2×100 mL). The layers were separated and the organic phase dried over magnesium sulfate. The mixture was filtered and concentrated in vacuo. The residue was dissolved in dioxane (10 mL) and treated with a lithium hydroxide solution (0.5 mL, 2.0 M), and the resulting mixture was stirred at room temperature overnight. The resulting mixture was poured into a saturated ammonium chloride solution and extracted with methylene chloride (2×150 mL). The layers were separated and the organic phase dried over magnesium sulfate. The mixture was filtered and concentrated in vacuo. The residue was purified by flash chromatography (silica gel, 24 g, 1% to 10% methanol in dichloromethane) to give acetic acid 2-[5-(5-azetidin-1-ylmethyl-1-methyl-1H-pyrazol-3-ylamino)-1-methyl-6-oxo-1,6-dihydro-pyridazin-3-yl]-6-(6-tert-butyl-8-fluoro-1-oxo-1H-phthalazin-2-yl)-benzyl ester (112 mg, 32%) as an off white solid: mp. 214-217° C.; 1H NMR (300 MHz, DMSO-d6) δ ppm 1.01-1.55 (m, 10H) 1.72-2.08 (m, 2H) 2.90-3.67 (m, 11H) 4.28-4.62 (m, 3H) 6.08 (s, 1H) 7.22-8.08 (m, 6H) 8.50 (d, J=1.89 Hz, 1H) 9.15 (s, 1H).

Aufarbeitung

  1. additionwas added
  2. temperatureThe resulting mixture was cooled
  3. extractionextracted with methylene chloride (2×100 mL)
  4. customThe layers were separated
  5. dry with materialthe organic phase dried over magnesium sulfate
  6. filtrationThe mixture was filtered
  7. concentrationconcentrated in vacuo
  8. dissolutionThe residue was dissolved in dioxane (10 mL)
  9. additiontreated with a lithium hydroxide solution (0.5 mL, 2.0 M)
  10. additionThe resulting mixture was poured into a saturated ammonium chloride solution
  11. extractionextracted with methylene chloride (2×150 mL)
  12. customThe layers were separated
  13. dry with materialthe organic phase dried over magnesium sulfate
  14. filtrationThe mixture was filtered
  15. concentrationconcentrated in vacuo
  16. customThe residue was purified by flash chromatography (silica gel, 24 g, 1% to 10% methanol in dichloromethane)

Quellen und Nachweise

ORD-Eintrag
ord-ce277917a3a0448a898741d5b797c187
Quelldatensatz
uspto-grants-2013_07
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08481540B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion